• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CinCor Pharma, Inc. - Common Stock (NQ:CINC)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 29.16 (3)
Ask (Size) 29.25 (9)
Prev. Close 29.06
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 43,764,323
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat
February 21, 2023
From CinCor Pharma Inc
Via GlobeNewswire
News headline image
There's a Lot to Love About Mineralys' Valentine's Day IPO
February 13, 2023
MLYS added 20% more shares to IPO funding, which goes live on 2/14. The bump secured liquidity to stabilize development, improving market cap to $683 million 
Via MarketBeat
Topics Initial Public Offering

Performance

More News

Read More
News headline image
These 2 Healthcare Stocks Have Doubled in 2023
February 01, 2023
Via MarketBeat
News headline image
CINCOR PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CinCor Pharma, Inc. - CINC
January 24, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
Where CinCor Pharma Stands With Analysts ↗
January 12, 2023
Via Benzinga
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT)
January 20, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Why These Two Biotech Stocks Blasted Higher This Week ↗
January 13, 2023
Via The Motley Fool
News headline image
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review ↗
January 13, 2023
Via Investor's Business Daily
News headline image
CINCOR PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CinCor Pharma, Inc. - CINC
January 10, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
AstraZeneca Stock Nabs Breakout After $1.8 Billion CinCor Buyout ↗
January 10, 2023
Via Investor's Business Daily
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT)
January 10, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
S&P 500 Gains 0.6%; Albireo Pharma Shares Spike Higher ↗
January 09, 2023
Via Benzinga
News headline image
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
January 09, 2023
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session ↗
January 09, 2023
Via Benzinga
News headline image
Stocks Building Off Of Friday's Rally ↗
January 09, 2023
Via Talk Markets
News headline image
Nasdaq Surges Over 200 Points; Crude Oil Rises 2% ↗
January 09, 2023
Via Benzinga
News headline image
CinCor Pharma (NASDAQ: CINC) Enters Into Agreement to be Acquired by AstraZeneca (NASDAQ: AZN) for $1.3 Billion
January 09, 2023
Via Spotlight Growth
News headline image
AstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion Deal ↗
January 09, 2023
Via Investor's Business Daily
News headline image
Why Is CinCor (CINC) Stock Up 138% Today? ↗
January 09, 2023
Via InvestorPlace
News headline image
Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday ↗
January 09, 2023
Via Benzinga
News headline image
US Stocks Open Higher; Dow Rises 150 Points ↗
January 09, 2023
Via Benzinga
News headline image
CINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CinCor Pharma, Inc. Is Fair to Shareholders
January 09, 2023
From Halper Sadeh LLC
Via Business Wire
News headline image
Tesla's Delivery Wait Times Go Up, China Wants To Secure License For Generic Version Of Pfizer's Paxlovid, India-Made iPhone Exports Surpass $2.5B: Today's Top Stories ↗
January 09, 2023
Via Benzinga
News headline image
AstraZeneca To Acquire CinCor Pharma To Strengthen Cardiorenal Pipeline ↗
January 09, 2023
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
January 09, 2023
Via Benzinga

Frequently Asked Questions

Is CinCor Pharma, Inc. - Common Stock publicly traded?
Yes, CinCor Pharma, Inc. - Common Stock is publicly traded.
What exchange does CinCor Pharma, Inc. - Common Stock trade on?
CinCor Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CinCor Pharma, Inc. - Common Stock?
The ticker symbol for CinCor Pharma, Inc. - Common Stock is CINC on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap